Current location - Loan Platform Complete Network - Big data management - Proportion of infectious disease detection market to clinical detection market
Proportion of infectious disease detection market to clinical detection market
At present, the overall scale of the diagnosis market in the field of infection is still expanding, from1243 million yuan in 20 16 years to 45.96 billion yuan in 2020, with a compound annual growth rate of 38.7%. It is estimated that the market size of infection diagnosis in China will reach 32.26 billion yuan in 2022.

Source: Frost &; Sullivan, China Institute of Commercial Industry.

market share

The proportion of molecular diagnosis in China's overall infection diagnosis market is also increasing, among which the immunological detection market accounts for a relatively large proportion, reaching 46.3%; The total ratio of DNA molecular diagnosis (mainly routine PCR) and RT-PCR is 365,438+0.5%. The RNA molecular diagnosis (isothermal amplification method) in the field of infection in China only accounts for 5. 1% of the whole infection molecular diagnosis market.

The status of RNA molecular diagnosis (isothermal amplification method) in the whole infection field is relatively low, and the main reason why it has not become the mainstream diagnosis method is that RNA is unstable in structure, easy to degrade and difficult in basic research. Therefore, among pathogens containing both DNA and RNA, RNA research is later than DNA, which restricts the application of RNA molecular diagnosis.

Source: Frost &; Sullivan, China Institute of Commercial Industry.

Subdivide the market size in the technical field

In terms of market share, immunodiagnosis is the mainstream diagnostic method with the highest market share in the field of infection at present, and the market scale has increased from 7.97 billion yuan in 20 16 to 23.29 billion yuan in 2020; RT-PCR is the fastest developing diagnostic method in the field of infection, and its market scale has increased from 66,543,800 million yuan in 2065,438+06 to 65,438,000 million yuan in 2020. The market scale of RNA molecular diagnosis (isothermal amplification method) increased from 2065438+2006 to 460 million in 2020. It is estimated that in 2022, the market scale of immunoassay, microbial culture, DNA molecular diagnosis, RT-PCR and RNA molecular diagnosis in China will reach 654.38+0.625 billion yuan, 565.438+0.3 billion yuan, 565.438+0.7 billion yuan, 4.68 billion yuan and 654.38+0.3 billion yuan respectively.

Source: Frost &; Sullivan, China Institute of Commercial Industry.

For more information, please refer to the Research Report on Market Prospects and Opportunities of in vitro Diagnosis Industry in China issued by China Commercial Industry Research Institute, which also provides services such as industrial big data, industrial intelligence, industrial research report, industrial planning, park planning, the Tenth Five-Year Plan, and industrial investment promotion.